Clinical Trials
15 trialsNCT05297734 2026-04-30
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Stanford University
Phase NA Recruiting
NCT07165691 2025-12-02
TELESCOPE-H
Rutgers, The State University of New Jersey
Phase NA Recruiting
NCT06988943 2025-05-30
Early Intervention Strategies for Lung Cancer
The First Affiliated Hospital of Guangzhou Medical University
Phase NA Recruiting
NCT06177925 2023-12-20
A Phase â…¡ Clinical Study of Adebrelimab Combined With Chemotherapy and Concurrent Radiotherapy for Extensive-Stage Oligometastatic SCLC
Nanfang Hospital, Southern Medical University
Phase 2 Recruiting
NCT02871856 2023-12-05
ILST
The University of Queensland
Phase NA Unknown
NCT02904954 2023-10-11
Durvalumab (MEDI4736) With or Without SBRT in Clinical Stage I, II and IIIA Non-small Cell Lung Cancer
Weill Medical College of Cornell University
Phase 2 Completed
NCT01860898 2022-09-28
A Phase I Study of iPS Cell Generation From Patients With COPD
Mayo Clinic
Phase NA Completed
NCT01999985 2020-11-27
Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC)
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Completed
NCT03402048 2020-11-04
EPIC
University of Turin, Italy
Phase 3 Unknown
NCT04371796 2020-05-01
Sintilimab (IBI308) in the Neoadjuvant Treatment of Patients With Resectable II-IIIA NSCLC
Sichuan Cancer Hospital and Research Institute
Phase 2 Unknown
NCT04133337 2019-10-21
Apatinib Combined With SHR-1210 Injection in the Treatment of Patients With Removable IB-IIIA NSCLC
Sichuan Cancer Hospital and Research Institute
Phase 1/2 Unknown
NCT03389256 2018-01-03
Apatinib in the Treatment of Patients With EGFR T790M-Negative NSCLC
Sichuan Cancer Hospital and Research Institute
Phase 2 Unknown
NCT01024413 2017-03-01
Phase III Trial to Evaluate the Elortinib vs Gefitinib in Advanced NSCLC With EGFR Exon 19 or 21 Mutations
Chinese Society of Lung Cancer
Phase 3 Completed
NCT02913365 2016-09-23
Etiologies, Investigations and Outcomes of Patients Presenting With Hemoptysis
Université de Sherbrooke
Unknown
NCT02406053 2015-04-02
Oxidative Damage and Antioxidant Mechanisms in COPD
Yuzuncu Yil University
Completed